Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-332940
Filing Date
2026-08-04
Accepted
2026-08-04 16:30:46
Documents
76
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adpt-20260630.htm   iXBRL 10-Q 3287750
2 EX-31.1 adpt-ex31_1.htm EX-31.1 19243
3 EX-31.2 adpt-ex31_2.htm EX-31.2 19237
4 EX-32.1 adpt-ex32_1.htm EX-32.1 11947
5 EX-32.2 adpt-ex32_2.htm EX-32.2 13340
  Complete submission text file 0001193125-26-332940.txt   12006971

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT adpt-20260630.xsd EX-101.SCH 1313331
79 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20260630_htm.xml XML 2413258
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38957 | Film No.: 261239303
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)